Induction of Differentiation of African Burkitt's Lymphoma Cells by Phorbol Ester: Possible Relation with Early B Cells

References

• Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46: 218–223
   PubMed Web of Science ®Google Scholar
• Berard CW, O'Conor GT, Thomas CB. Histopathological definition of Burkitt's tumor. Bull WHO 1969; 40: 601–607
   PubMed Web of Science ®Google Scholar
• Mann RB, Jaffe ES, Braylan RC. Nonendemic Burkitt's lymphoma: American Burkitt cell tumor related to germinal centers. N Engl J Med 1976; 295: 685–691
   PubMed Web of Science ®Google Scholar
• Arseneau JC, Canellos GP, Banks PM. American Burkitt's lymphoma: A clinicopathologic study of 30 cases. 1. Clinical factors relating to prolonged survival. Am J Med 1975; 58: 314–321
   PubMed Web of Science ®Google Scholar
• Banks PM, Arseneau JC, Gralnick HR. American Burkitt's lymphoma: A clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med 1975; 58: 322–329
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Collins RD. New approaches to the classification of the lymphomata. Br J Cancer 1975; 31: 1–28, suppl. 2
   PubMed Web of Science ®Google Scholar
• Mann RB, Jaffe ES, Berard CW. Malignant lymphomas-a conceptual understanding of morphologic diversity. Am J Pathol 1979; 94: 105–175
   PubMed Web of Science ®Google Scholar
• Hsu SM, Jaffe ES. Pnenotypic expression of B-lymphocytes. I. Identification with monoclonal antibodies in normal lymphoid tissues. Am J Pathol 1984; 114: 387–395
   PubMed Web of Science ®Google Scholar
• Kadin ME, Berard CW, Nanba K. Lymphoproliferative diseases in Japan and Western countries. Human Pathol 1983; 14: 745–772
   PubMed Web of Science ®Google Scholar
• Bollum FJ. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 1979; 54: 1203–1215
   PubMed Web of Science ®Google Scholar
• Greaves MF, Brown G, Rapson NT. Antisera to acute lymphoblastic leukemia cell. Clin Immunol Immunopathol 1975; 4: 67–84
   PubMedGoogle Scholar
• Ritz J, Pesando JM, Notis-McConarty J. A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature 1980; 283: 583–585
   PubMed Web of Science ®Google Scholar
• Rovera G, O'Brien TG, Diamond L. Induction of differentiation in human promeylocytic leukemia cells by tumor promoters. Science 1979; 204: 868–870
   PubMed Web of Science ®Google Scholar
• Humberman E, Challaham MF. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor promoting agents. Proc Natl Acad Sci (USA) 1979; 76: 1293–1297
   PubMed Web of Science ®Google Scholar
• Lotem J, Sachs L. Regulation of normal differentiation in mice and human myeloid leukemic cells by phorbolesters and the mechanism of tumor promotion. Proc Natl Acad Sci (USA) 1979; 76: 5158–5162
   PubMed Web of Science ®Google Scholar
• Tottermann TH, Nilsson K, Sundstrom C. Phorbol ester induced differentiation of chronic lymphocytic leukemia cells. Nature (Lond.) 1980; 288: 176–178
   PubMed Web of Science ®Google Scholar
• Negasawa K, Mak TW. Phorbol esters induced differentiation in human malignant T lymphoblasts. Proc Natl Acad Sci (USA) 1980; 77: 2964–2968
   PubMed Web of Science ®Google Scholar
• Tucker WL, Fred JB, Walid GY. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line:model for human lymphoid progenitor cell development. J Immunol 1982; 128: 1316–1320
   PubMed Web of Science ®Google Scholar
• Braziel RM, Keneklis T, Donlon JA. Terminal deoxy-nucleotidyl transferase in non-Hodgkins lymphoma. Am J Clin Pathol 1983; 80: 655–659
   PubMed Web of Science ®Google Scholar
• McCaffrey R, Harrison TA, Parkman R. Terminal deoxy-nucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. N Engl J Med 1975; 292: 775–780
   PubMed Web of Science ®Google Scholar
• Bearman RM, Winberg CD, Maslow WC. Terminal deoxy-nucleotidyl transferase activity in neoplastic and non-neoplastic hematopoietic cells. Am J Clin Pathol 1981; 75: 794–802
   PubMed Web of Science ®Google Scholar
• Long JC, McCaffrey RP, Aisenberg AC. Terminal deoxy-nucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. Am J Med 1978; 64: 788–794
   PubMed Web of Science ®Google Scholar
• Minowada J, Sugawa K, Trowbridge IS. Marker profiles of 55 human leukemia-lymphoma cell lines. Malignant Lymphomas, Etiology, Immunology, Pathology, Treatment, Bristol-Meyers Cancer Symposium, JA Rosenberg, HS Kaplan. Academic Press, New York 1982; Vol. 3: 53–74
   Google Scholar
• Klein G, Manneborg A, Steinitz M. Differences on EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. Int J Cancer 1979; 23: 197–200
   PubMed Web of Science ®Google Scholar
• Klein G, Ehlin-Henriksson B, Schlossmann SF. Induction of an activated B lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by EBV conversion of an EBV-negative lymphoma line (Ramos): Differential effect of transforming (B95–8) and nontransforming (P3HR-1) EBV substrains. J Immunol 1983; 130: 1985–1989
   PubMed Web of Science ®Google Scholar
• Chang YW, Ayad AK, Caryl LL. Induction of HLA-DC/DS (Leu 10) antigen expression by human precursor B cell lines. J Exp Med 1983; 158: 1757–1762
   PubMed Web of Science ®Google Scholar
• Nadler LM, Ritz J, Bates MP. Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest 1982; 70: 433–442
   PubMed Web of Science ®Google Scholar
• Cossman J, Neckers LM, Arnold A. Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med 1982; 307: 1251–1254
   PubMed Web of Science ®Google Scholar
• Kersey JH, LeBien TW, Abramson CS. P24: A human leukemia-associated and lymphohaemopoietic cell surface structure identified with monoclonal antibody. J Exp Med 1981; 153: 726–731
   PubMed Web of Science ®Google Scholar
• Cossman J, Neckers LM, Hsu SM. Low-grade lymphomas: expression of developmentally regulated B-cell antigens. Am J Pathol 1984; 115: 117–124
   PubMed Web of Science ®Google Scholar
• Epstein AL, Variakojis D, Berger C. Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (Nu-DHL-1, Nu-DUL-1, and Nu-AmB-1) with chromosome translocations. Int J Cancer, in press
   Web of Science ®Google Scholar
• Abramson CS, Kersey JH, LeBien TW. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol 1981; 126: 83–88
   PubMed Web of Science ®Google Scholar
• Nadler LM, Stashenko P, Hardy R. Characterization of a human B cell specific antigen (B2) distinct from B1. J Immunol 1981; 126: 1941–1948
   PubMed Web of Science ®Google Scholar
• Gatenby PA, Kansas GS, Chen YX. Dissection of immuno-regulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol 1982; 129: 1993–2000
   PubMedGoogle Scholar
• Uchiyama R, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and functional mature T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 1981; 126: 1393–1397
   PubMed Web of Science ®Google Scholar
• Shackelford DA, Mann DL, Van Rood JJ. Human B-cell alloantigens DV1. MT1 and LB 12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci (USA) 1981; 78: 4566–4570
   PubMed Web of Science ®Google Scholar
• Goyert SM, Shively JE, Sliver J. Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J Exp Med 1982; 156: 550–566
   PubMed Web of Science ®Google Scholar
• Engleman EG, Warnke R, Fox RI. Studies of a human T lymphocyte antigen recognized by monoclonal antibody. Proc Natl Acad Sci (USA) 1981; 78: 1791–1795
   PubMed Web of Science ®Google Scholar
• Schwarting R, Stein H, Wang CY. The monoclonal antibodies anti-S-HCL-1 and anti-S-HCL-3 allow the diagnosis of hairy cell leukemia. Blood 1985; 65: 974–983
   PubMed Web of Science ®Google Scholar